

You will now be redirected to the GD3 website
Integrated Analytical Solutions, Inc. is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.
Learn more about GD3Leadership
Leverage our diverse team's decades of experience in laboratory management, instrument optimization, pharmaceutical science, and biotechnology to help you deliver safe, consistent, and high-quality cannabis products to consumers.

James Beasley, Ph.D.
Managing Director
Dr. Beasley is a highly accomplished scientist with a proven track record of success in analytical laboratory testing. He excels in developing and leading scientific and technological operations, overseeing teams of scientists in assay development, optimization, and execution. With a PhD in Chemistry from the University of North Carolina at Chapel Hill and postdoctoral training at Princeton University, Dr. Beasley has dedicated over 25 years to advancing scientific research and development. Throughout his career, Dr. Beasley has held key leadership positions at renowned pharmaceutical companies, including Ligand Pharmaceuticals, Pharmacopeia, and DGI Biotechnology. He has also served as the Discovery Biology Team Leader and Director of Biology at Venenum BioDesign and Genesis Drug Discovery & Development (GD3). Dr. Beasley's extensive experience in assay development, optimization, and execution, coupled with his strong leadership skills, has enabled him to deliver innovative solutions and drive scientific excellence consistently.

Andy Zhao, Ph.D.
Team Leader
Dr. Zhao is a seasoned analytical chemist with a Ph.D. in Physical Chemistry from the Chinese Academy of Sciences. Currently serving as a Team Leader at IAS, Dr. Zhao oversees and leads a team of scientists specializing in LC-MS/MS analysis. His expertise lies in experimental design, data interpretation, method development and optimization, and talent development. Prior to his current role, Dr. Zhao held positions at Pharmaron and High North Laboratories. At Pharmaron, he focused on developing and validating assays for small and large molecules. At High North Laboratories, he managed the analytical laboratory, overseeing routine sample analysis, method development and validation for cannabis products, and ensuring compliance with regulatory standards. Dr. Zhao brings a wealth of experience in LC-MS/MS, GC-MS, ICP-MS, and HPLC techniques to his work. His strong analytical skills, coupled with a deep understanding of scientific principles, enable him to deliver accurate and reliable results.

Managing Director
